AI Regulation in US Federal
US Federal has 200 tracked AI regulatory updates across 5 frameworks. This page provides an overview of the current regulatory landscape, upcoming deadlines, and recent enforcement activity.
Upcoming Deadlines
Deadline for public feedback on generative AI-enabled medical devices
FDA continues AI-enabled medical device guidance and submissions workflow updatesRecent Regulatory Updates
FDA AI-enabled medical device and PCCP guidance baseline
FDA’s August 2025 PCCP guidance provides recommendations for planned modifications to AI-enabled devices reviewed through the 510(k), De Novo and PMA pathways.
SEC announces internal AI task force
The SEC announced an internal AI task force on 1 August 2025 to coordinate responsible AI adoption across the agency; the announcement does not introduce a new external compliance obligation.
FTC AI enforcement actions on deceptive claims and substantiation
These records cover separate FTC proceedings concerning AI claims, an AI companion chatbot inquiry, and the later setting aside of the Rytr order; they do not establish a common new compliance deadline.
FTC AI enforcement posture remains active across deceptive claims and AI investments
The FTC’s AI hub and related matters, including Rytr, Workado, and DoNotPay, show that the agency continues to police deceptive AI claims and conduct, so AI product and marketing teams should assume ongoing enforcement scrutiny now.
FDA continues AI-enabled medical device guidance and submissions workflow updates
FDA’s AI-enabled medical device materials show an active draft-guidance and feedback cycle, with public feedback on generative AI-enabled medical devices due by 2026-10-19, so device teams need to prepare submission and validation materials now.
FTC finalizes orders against Cox Media Group and two other firms over deceptive AI-powered marketing claims
On 2026-08-27, the FTC finalized orders and $930,000 in settlements after alleging the firms falsely claimed an AI-powered “active listening” ad service and deceptive customer consent, creating immediate enforcement risk for any AI marketing claims that are not fully substantiated.
Historical Congressional source: no current AI obligation identified
The linked source is a 1996 Congressional bill record and does not establish a current AI compliance update. It is retained here to explain the correction to the earlier entry.
FDA draft guidance for developers of AI-enabled medical devices
FDA’s January 2025 draft guidance for AI-enabled medical devices puts lifecycle documentation, transparency, maintenance, and bias controls front and center, so device teams should align submissions and post-market processes now.
DoNotPay final order on deceptive AI lawyer claims
The FTC finalized its DoNotPay order in February 2025, prohibiting deceptive AI lawyer claims and requiring monetary relief and notice, which raises the bar for substantiation of legal-assistance AI products.
MindSift LLC matter
The FTC matter against MindSift alleges deceptive AI-powered active-listening and opt-in claims, underscoring immediate enforcement risk where AI functionality or data-collection claims are overstated.
FTC AI enforcement and policy hub
The FTC’s AI hub consolidates recent AI enforcement and policy actions, reinforcing that deceptive or unsubstantiated AI capability claims remain an active Section 5 enforcement risk for vendors and deployers.
FDA final guidance on clinical decision support software
FDA’s January 2026 final guidance clarifies when clinical decision support software is outside device regulation and when FDA oversight still applies, so AI health tools must be re-triaged immediately against the final criteria.
FTC inquiry into AI chatbots acting as companions
The FTC has launched a formal inquiry into AI companion chatbots, signaling intensified scrutiny of data practices, age protections, and safety controls even before any new rulemaking or enforcement order is issued.
FTC final order against Workado for misleading AI accuracy claims
The FTC has entered a final order against Workado over false claims about AI content-detection accuracy, requiring substantiation and multi-year compliance reporting, so AI marketing claims must now be treated as an active enforcement risk.
NIST AI RMF update process tied to White House AI Action Plan
NIST says the AI RMF 1.0 is being revised under the July 23, 2025 White House AI Action Plan, which means organizations relying on the framework should expect updated implementation guidance and profile changes rather than a static reference.
Applicable Frameworks
Key Topics
Weekly digest
Leave your email to get each issue in your inbox. Free, no account required.
We use your email only for the digest. Privacy policy